Ledger.Open graph →
SEC Form D · filed July 24, 2019

Israel Biotech Fund II, L.P

Offering
$100.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Pooled Investment Fund
Location
REHOVOT, L3
Type
Pooled fund

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (4)

Ido Zairi · Tel Aviv, L3ExecDavid Sidransky · Somerset, NJExecYuval Cabilly · Tel Aviv, L3ExecIdo Zairi · Tel Aviv, L3Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗